Jarro-Dophilus Infant Probiotics

Suggested/Recommended/Usage/Directions

Usage: For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.

Storage

Storage instructions: Does not require refrigeration and can be stored at room temperature Avoid storage at temperature above 77(0) F (25(0) C).

Brand IP Statement(s) re: (c), (TM), (SM)

2017 Jarrow Formulas

General Statements: All Other Content

Liquid drops

Seals/Symbols

Room Temperature Tolerant

Formula re: Type

Promotes infant intestinal health

FDA Statement of Identity

Liquid Probiotic Supplement

Formulation re: Does NOT Contain

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

General: Product/Version Code

12417BABDROP PROD # 103014

Formulation re: Vegetarian/Vegan

Suitable for vegans/vegetarians.

Seals/Symbols

Gluten Free

Seals/Symbols

V Vegan

Brand IP Statement(s) re: (c), (TM), (SM)

Strains Matter

General Statements: All Other Content

Jarrow Formulas’ Probiotics contain documented strains

Brand IP Statement(s) re: (c), (TM), (SM)

U.S. Patent-Pending

Formula re: Contains

1 Billion per serving Bifidobacterium Longum Subsp. Infantis M-63

General Statements: All Other Content

Minimum 1 billion viable cells at time of consumption, under recommended conditions and within Best Used Before date.

Formula re: Contains

Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants. B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species. Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements: All Other Content

The Developing Intestinal Microflora of Newborns Is Up to 90% B. Infantis